Suppr超能文献

接种疫苗和注射痕量矿物质后感染牛病毒性腹泻病毒 2 和牛疱疹病毒 1 的奶牛犊上呼吸道的临床状况和内窥镜检查。

Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.

机构信息

Group for Reproduction in Animals, Vaccinology & Infectious Diseases (GRAVID™), College of Veterinary Medicine, University of Georgia, Athens, GA 30602-2771, United States; Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States.

Group for Reproduction in Animals, Vaccinology & Infectious Diseases (GRAVID™), College of Veterinary Medicine, University of Georgia, Athens, GA 30602-2771, United States; Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA 30602, United States.

出版信息

Res Vet Sci. 2022 Dec 20;152:582-595. doi: 10.1016/j.rvsc.2022.09.026. Epub 2022 Sep 28.

Abstract

The objective was to compare clinical protection [evaluated through health scoring, endoscopy score of the upper respiratory tract (URT-ES), leukocyte count, viremia, and virus shedding in nasal secretions] following Bovine viral diarrhea virus 2 (BVDV2) and Bovine herpes virus 1 (BHV1) challenge among calves submitted to modified-live virus (MLV) booster vaccination (either intranasal or subcutaneous) concurrent with injectable trace minerals (ITM) or saline. Forty-eight dairy calves received an MLV intranasal (IN) vaccine containing BHV1, BRSV, and BPIV and subcutaneous (SC) ITM (Se, Cu, Zn & Mn; ITM, n = 24) or saline (SAL, n = 24). Ten weeks later, calves received a second dose of ITM, or saline, according to previous groups and were randomly assigned to receive the same IN vaccine [ITM-IN (n = 12), SAL-IN (n = 12)] or a SC MLV vaccine containing BHV1, BRSV, BPI3V, BVDV1 & 2 [ITM-SC (n = 12), SAL-SC (n = 12)]. Additionally, 12 calves did not receive vaccine or treatment and served as a control group (UNVAC, n = 12). Forty-nine days after booster, calves were challenged with BVDV2; and seven days later with BHV1. Health scores indicated disease in UNVAC on days 6, 10 and 12 compared to the vaccinated groups. Unvaccinated calves had the highest URT-ES after BHV1 challenge. Calves that received SC booster had lower URT-ES after BHV1 challenge than UNVAC calves. Calves in ITM-IN had significantly lower URT-ES after BHV1 infection than SAL-IN and UNVAC calves. In conclusion, IN or SC MLV vaccination was similarly effective in protecting calves from BVDV2 + BHV1 challenges (reducing clinical and endoscopy scores, preventing leukopenia, and viremia), compared to unvaccinated calves. Endoscopic evaluation of the URT allowed visualization of the inflammation and damage at multiple depths in the URT caused by a serial BVDV2 + BHV1 challenge. Calves that received SC vaccination had significantly lower URT-ES after BHV1 challenge than the UNVAC calves. Administration of ITM concurrent with IN vaccination was associated with reduced URT inflammation after BVDV2 + BHV1 challenge.

摘要

目的是比较牛病毒性腹泻病毒 2 型(BVDV2)和牛疱疹病毒 1 型(BHV1)攻毒后,接受改良活病毒(MLV)加强免疫接种(鼻内或皮下)同时给予注射微量元素(ITM)或生理盐水的小牛的临床保护(通过健康评分、上呼吸道内镜评分(URT-ES)、白细胞计数、病毒血症和鼻分泌物中的病毒脱落来评估)。48 头奶牛犊接受了含有 BHV1、牛呼吸道合胞体病毒(BRSV)和牛副流感病毒 3 型(BPIV)的 MLV 鼻内(IN)疫苗和皮下(SC)ITM(Se、Cu、Zn 和 Mn;ITM,n=24)或生理盐水(SAL,n=24)。10 周后,根据之前的分组,小牛再次接受 ITM 或生理盐水,并随机分为接受相同 IN 疫苗[ITM-IN(n=12),SAL-IN(n=12)]或含有 BHV1、BRSV、BPI3V、BVDV1 和 2 的 SC MLV 疫苗[ITM-SC(n=12),SAL-SC(n=12)]。此外,12 头小牛未接种疫苗或接受治疗,作为对照组(UNVAC,n=12)。加强免疫接种后 49 天,小牛感染 BVDV2;7 天后感染 BHV1。与接种疫苗的组相比,UNVAC 组在第 6、10 和 12 天的健康评分表明存在疾病。未接种疫苗的小牛在感染 BHV1 后 URT-ES 最高。接受 SC 加强免疫接种的小牛在感染 BHV1 后 URT-ES 低于 UNVAC 小牛。接受 ITM-IN 接种的小牛在感染 BHV1 后 URT-ES 明显低于 SAL-IN 和 UNVAC 小牛。总之,与未接种疫苗的小牛相比,IN 或 SC MLV 疫苗接种在预防 BVDV2+BHV1 攻毒方面同样有效(降低临床和内镜评分,预防白细胞减少症和病毒血症)。对 URT 的内镜评估允许在 URT 中可视化由一系列 BVDV2+BHV1 攻毒引起的炎症和损伤的多个深度。接受 SC 疫苗接种的小牛在感染 BHV1 后 URT-ES 明显低于 UNVAC 小牛。同时给予 ITM 与 IN 接种相关,可降低 BVDV2+BHV1 攻毒后 URT 炎症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验